Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

Questcor Pharmaceuticals, Inc. (QCOR)

-NasdaqGS

36.01 May 22, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 509,292   218,169   115,131  
Cost of Revenue28,555  12,459  8,013  
Gross Profit 480,737   205,710   107,118  
Operating Expenses
Research Development34,269  16,778  10,934  
Selling General and Administrative147,735  74,471  41,798  
Non Recurring987  299   -  
Others1,219  1,044  546  
Total Operating Expenses184,210  92,592   -  
Operating Income or Loss 296,527   113,118   53,840  
Income from Continuing Operations
Total Other Income/Expenses Net703  627  533  
Earnings Before Interest And Taxes297,230  113,745  54,373  
Interest Expense -   -   -  
Income Before Tax297,230  113,745  54,373  
Income Tax Expense99,555  34,154  19,302  
Minority Interest -   -   -  
Net Income From Continuing Ops197,675  79,591  35,071  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 197,675   79,591   35,071  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 197,675   79,591   35,071  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.